--- title: Erisyon slug: erisyon-133f9 url: /detay/erisyon-133f9 type: article language: English entity: primary: Erisyon type: article categories: - name: Energy slug: enerji url: /kategori/enerji - name: Engineering slug: muhendislik url: /kategori/muhendislik - name: Technology And Innovation slug: teknoloji url: /kategori/teknoloji tags: - Erisyon author: Ömer Said Aydın created_at: 2025-10-25T16:04:11.839973+03:00 updated_at: 2025-10-31T16:35:30.460793+03:00 image: https://cdn.t3pedia.org/media/uploads/2025/10/25/8NgSrCZpFhu9ttLKdVtXpolJAfsUSqIl.jpg --- # Erisyon ## KURE Information Cards ![erisyon_logo.jpg](https://cdn.t3pedia.org/media/uploads/2025/10/25/vnnUwhq8GnY5qQLiKpcmCFsqn6K8xdo2.jpg) *Erisyon* | Field | Value | |-------|-------| | Website(s) | https://www.erisyon.com | | Founded(Text) | 2018 | | Headquarters | Austin, Texas, United States | ## Article Content **Erisyon** is a biotechnology company that has **commercialized the world’s first single-molecule protein sequencing technology**, pioneering a new era in **proteomics** with unmatched precision and scalability. The company’s platform, based on its proprietary **Fluorosequencing** method, enables direct, molecule-by-molecule analysis of [proteins](/en/detay/proteins/llms.txt)—offering powerful applications for **early disease detection, diagnostics, and therapeutic development**. ### **Founding and Background** **Erisyon Inc.** was founded in **2018** in the **United States**, emerging from over a decade of research at the **Center for Systems and Synthetic Biology** at **The University of Texas at Austin**. The founding team includes: - **Prof. Eric Anslyn** – Co-founder, Professor of Chemistry - **Prof. Edward Marcotte** – Co-founder, Professor of Molecular Biosciences - **Talli Somekh** – Chief Executive Officer (CEO) - **Jag Swaminathan** – Chief Technology Officer (CTO) - **Angela Bardo** – Vice President of Product Erisyon’s mission is to **translate academic breakthroughs into commercial technology** that allows direct understanding of biological systems at the molecular level. ### **Core Technology: Fluorosequencing** **Fluorosequencing** is a **single-molecule protein sequencing technique** that extends the revolution of DNA sequencing into the realm of proteins. The method involves: 1. Fragmenting proteins into peptides. 2. Labeling specific amino acids with **fluorescent tags**. 3. Sequencing each peptide **step-by-step through optical imaging**. The resulting **“fluorosequence”** data is matched to reference protein databases to identify individual proteins and their modifications. **Key Advantages:** - Single-molecule sensitivity - High throughput (hundreds of millions to billions of molecules analyzed simultaneously) - Low sample requirement and quantitative precision - Detection of low-abundance proteins beyond the reach of mass spectrometry or antibody-based assays ### **Applications** [Fluorosequencing](/en/detay/erisyon-8a893/llms.txt) enables early detection of **neurodegenerative diseases** such as **Parkinson’s disease** by distinguishing healthy from pathological forms of proteins like **alpha-synuclein**. This work, supported by the **Michael J. Fox Foundation**, demonstrates the potential for identifying **biomarkers years before symptom onset**. The technology identifies **tumor neoantigens** that interact with the immune system, even when present at very low abundance. This enhances the design of **personalized cancer immunotherapies** by mapping antigenic peptides undetectable by traditional proteomics. Erisyon’s method helps investigate **viral glycosylation patterns**—a key mechanism for immune evasion. By analyzing the **surface glycan structures of viruses** such as **SARS-CoV-2**, the platform provides early-warning insights and aids **vaccine development** strategies. In agricultural research, [Fluorosequencing](/en/detay/fluorosequencing-method/llms.txt) allows the **protein-level study of plant stress responses**, including **post-translational modifications** like phosphorylation. These insights guide the development of **stress-tolerant crop varieties** and contribute to **food security and agricultural sustainability**. The platform facilitates **molecular-level mapping of drug–protein interactions**, enabling the design of safer and more effective therapeutics. It also supports **enzyme engineering** for **eco-friendly industrial bioprocesses**. ### **Scientific Contributions** Erisyon’s foundational research has been featured in leading journals, including: - *Nature Biotechnology* - *ACS Chemical Biology* - *PLOS Computational Biology* These studies have demonstrated breakthroughs in **single-molecule protein identification**, **peptide sequencing chemistry**, and **computational modeling**. ### **Impact and Vision** Erisyon represents a paradigm shift in proteomics—moving beyond genetic data to directly decode biological function at the **protein level**. Its **Fluorosequencing** technology combines **high sensitivity, accuracy,** and **scalability**, enabling transformative advances in: - **Early disease diagnosis** - **Personalized medicine** - **Comprehensive molecular understanding of life systems** ## Academic Sources and References 1. Erisyon. “About.” Official Website. Accessed October 22, 2025. https://www.erisyon.com/about.Erisyon. “Applications.” Official Website. Accessed October 22, 2025. https://www.erisyon.com/applications.Erisyon. “Fluorosequencing.” Official Website. Accessed October 22, 2025. https://www.erisyon.com/#fluorosequencing.Erisyon. “Home.” Official Website. Accessed October 22, 2025. https://www.erisyon.com/.Erisyon. “Technology.” Official Website. Accessed October 22, 2025. https://www.erisyon.com/technology.Erisyon. “About.” LinkedIn. Accessed October 22, 2025. https://www.linkedin.com/company/erisyon/?originalSubdomain=tr.